Literature DB >> 17267741

Plasmin(ogen) promotes renal interstitial fibrosis by promoting epithelial-to-mesenchymal transition: role of plasmin-activated signals.

Guoqiang Zhang1, Kelly A Kernan, Sarah J Collins, Xiaohe Cai, Jesús M López-Guisa, Jay L Degen, Yigal Shvil, Allison A Eddy.   

Abstract

Plasminogen (Plg) activator inhibitor-1 (PAI-1) is an important fibrosis-promoting molecule. Whether this effect can be attributed to PAI-1's activity as an inhibitor of plasmin generation is debated. This study was designed to investigate the role of Plg in renal fibrosis using in vivo and in vitro approaches. Plg-deficient (Plg-/-) and wild-type (Plg+/+) C57BL/6 mice were subjected to unilateral ureteral obstruction or sham surgery (n = 8/group; sham, days 3, 7, 14, and 21). Plg deficiency was confirmed by the absence of Plg mRNA, protein, and plasmin activity. After 21 d of unilateral ureteral obstruction, total kidney collagen was significantly reduced by 35% in the Plg-/- mice. Epithelial-to-mesenchymal transition (EMT), as typified by tubular loss of E-cadherin and acquisition of alpha-smooth muscle actin, was also significantly reduced in Plg-/- mice, 76% and 50%, respectively. Attenuation of EMT and fibrosis severity in the Plg-/- mice was associated with significantly lower levels of phosphorylated extracellular signal-regulated kinase (ERK) and active TGF-beta. In vitro, addition of plasmin (20 microg/ml) to cultures of murine tubular epithelial cells initiated ERK phosphorylation within minutes, followed by phenotypic transition to fibroblast-specific protein-1+, alpha-smooth muscle actin+, fibronectin-producing fibroblast-like cells. Both plasmin-induced ERK activation and EMT were significantly blocked in vitro by the protease-activated receptor-1 (PAR-1) silencing RNA; by pepducin, a specific anti-PAR-1 signaling peptide; and by the ERK kinase inhibitor UO126. Plasmin-induced ERK phosphorylation was enhanced in PAR-1-overexpressing tubular cells. These findings support important profibrotic roles for plasmin that include PAR-1-dependent ERK signaling and EMT induction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17267741     DOI: 10.1681/ASN.2006080886

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  39 in total

1.  Vitronectin accumulates in the interstitium but minimally impacts fibrogenesis in experimental chronic kidney disease.

Authors:  Jesús M López-Guisa; Allen C Rassa; Xiaohe Cai; Sarah J Collins; Allison A Eddy
Journal:  Am J Physiol Renal Physiol       Date:  2011-01-26

2.  Role of tubulointerstitial plasmin in the progression of IgA nephropathy.

Authors:  Takahiro Uchida; Takashi Oda; Hanako Takechi; Hidehito Matsubara; Atsushi Watanabe; Kojiro Yamamoto; Naoki Oshima; Yutaka Sakurai; Takako Kono; Hideyuki Shimazaki; Seiichi Tamai; Hiroo Kumagai
Journal:  J Nephrol       Date:  2015-05-14       Impact factor: 3.902

3.  The antifibrinolytic drug tranexamic acid reduces liver injury and fibrosis in a mouse model of chronic bile duct injury.

Authors:  Nikita Joshi; Anna K Kopec; Keara Towery; Kurt J Williams; James P Luyendyk
Journal:  J Pharmacol Exp Ther       Date:  2014-03-14       Impact factor: 4.030

Review 4.  Pharmacology, biodistribution, and efficacy of GPCR-based pepducins in disease models.

Authors:  Sarah L Tressel; Georgios Koukos; Boris Tchernychev; Suzanne L Jacques; Lidija Covic; Athan Kuliopulos
Journal:  Methods Mol Biol       Date:  2011

5.  Amelioration of glomerulosclerosis with all-trans retinoic acid is linked to decreased plasminogen activator inhibitor-1 and α-smooth muscle actin.

Authors:  Xia Liu; Lei Lü; Bei-bei Tao; Ai-ling Zhou; Yi-chun Zhu
Journal:  Acta Pharmacol Sin       Date:  2011-01       Impact factor: 6.150

6.  Clusterin attenuates the development of renal fibrosis.

Authors:  Gwon-Soo Jung; Mi-Kyung Kim; Yun-A Jung; Hye-Soon Kim; In-Sun Park; Bon-Hong Min; Ki-Up Lee; Jung-Guk Kim; Keun-Gyu Park; In-Kyu Lee
Journal:  J Am Soc Nephrol       Date:  2011-11-03       Impact factor: 10.121

7.  Angiotensinogen, angiotensine converting enzyme and plasminogen activator inhibitor-1 gene polymorphism in chronic allograft dysfunction.

Authors:  Negar Azarpira; M Bagheri; Gh A Raisjalali; M H Aghdaie; S Behzadi; H Salahi; M Rahsaz; M Darai; M J Ashraf; B Geramizadeh
Journal:  Mol Biol Rep       Date:  2008-05-03       Impact factor: 2.316

Review 8.  New insights into epithelial-mesenchymal transition in kidney fibrosis.

Authors:  Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2009-12-17       Impact factor: 10.121

Review 9.  Serine proteases, inhibitors and receptors in renal fibrosis.

Authors:  Allison A Eddy
Journal:  Thromb Haemost       Date:  2009-04       Impact factor: 5.249

10.  A novel signaling pathway: fibroblast nicotinic receptor alpha1 binds urokinase and promotes renal fibrosis.

Authors:  Guoqiang Zhang; Kelly A Kernan; Alison Thomas; Sarah Collins; Yumei Song; Ling Li; Weizhong Zhu; Renee C Leboeuf; Allison A Eddy
Journal:  J Biol Chem       Date:  2009-08-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.